Skip to Content

Newsletter No. 65 -- August 2003

FROM: Cancer Imaging Program, National Cancer Institute, August, 2003.

CIP Web Site: http://cip.cancer.gov/

CANCER IMAGING PROGRAM is our new name. 

Meetings

IMAGING IN 2020 III

Conference on Molecular Imaging, September 7-11, 2003, Jackson Hole, Wyoming.

URL:  http://www.imagingin2020.com/

AMI INTERNATIONAL CONFERENCE 2003

September 21-27, 2003

Institute for Molecular Imaging/HiRes (9/21-24/2003, Melia Castilla Hotel)
Society of Non-Invasive Imaging in Drug Development (9/24-26/2003, Melia Castilla Hotel)
Institute for Clinical PET (9/26-27/2003, NH Eurobuilding Hotel)
URL:  http://www.ami-imaging.org/conference2003/

ACRIN (AMERICAN COLLEGE OF RADIOLOGY IMAGING NETWORK)

Fall meeting, September 19-21, 2003, Ritz-Carlton Pentagon City, Arlington, VA

URL:  http://www.acrin.org

Announcement

The Cancer Imaging Program of the NCIrequests submissions for its Development of Clinical Imaging Drugs and Enhancers (DCIDE) initiative.  The goal is the rapid movement of promising, novel cancer imaging enhancers or molecular probes from the laboratory to proof-of-principle clinical trials.  See the web site for details.

URL:  http://www3.cancer.gov/bip/dcide.htm

NIH

1. SMALL ANIMAL IMAGING RESOURCE PROGRAMS (NCI) (CA-04-011)

Expected Letter of Intent Deadline: October 20, 2003

Expected Application Deadline: November 17, 2003

The NCI Board of Scientific Advisors has approved reissuing the Cancer Imaging Program's Small Animal Imaging Resource Program (SAIRP) initiative.  The total funding for the initiative is $18.3M, with $4.5M available in the first year; it is expected that 5 SAIRPs will be funded. 

Information will be available in the NIH Guide.  The discussion at the BSA meeting will be available at http://deainfo.nci.nih.gov/advisory/bsa.htm   A short description of the approved initiative appears with Recently Cleared Concepts at http://deainfo.nci.nih.gov/concepts/CA-04-011.htm

URL for NIH Guide: http://grants1.nih.gov/grants/guide/index.html

2. INDUSTRY-ACADEMIC PARTNERSHIPS FOR DEVELOPMENT OF BIOMEDICAL IMAGING SYSTEMS AND METHODS THAT ARE CANCER SPECIFIC (R21) (PAR-03-157) LETTER OF INTENT RECEIPT DATES:  October 22, 2003; October 20, 2004 APPLICATION RECEIPT DATES:  November 19, 2003; November 17, 2004 

The intent of this initiative is to encourage industry-academic partnerships by making "seed" grants available for the pursuit of collaborative in vivo imaging research projects directed at cancer. Support for the exchange of scientists between industry and academia can be requested under this initiative. URL: http://grants1.nih.gov/grants/guide/pa-files/PAR-03-157.html

3.  INTERAGENCY COUNCIL ON BIOMEDICAL IMAGING IN ONCOLOGY

Next Due Date for Requests - Monday, October 13 (for November 24 meeting)

The Interagency Council on Biomedical Imaging in Oncology brings together technology developers and representatives from the National Cancer Institute (NCI), Food and Drug Administration (FDA), and Centers for Medicare and Medicaid (CMS) to expedite the process of bringing new products to market. The Council provides advice from a multi-agency perspective on the spectrum of scientific, regulatory, and reimbursement issues related to developing your imaging device or technology.  Fill out the one-page Request to Present. 

URL:http://www3.cancer.gov/dctd/icbio

4. ACADEMIC PUBLIC PRIVATE PARTNERSHIP PROGRAM (AP4) PLANNING GRANT (RFA-CA-04-005) (NCI) LETTER OF INTENT RECEIPT DATE:  October 21, 2003 APPLICATION RECEIPT DATE:  November 20, 2003 The Developmental Therapeutics Program (DTP), Division of Cancer Treatment and Diagnosis (DCTD), National Cancer Institute (NCI) invites academic cancer researchers to participate in the Academic Public Private Partnership Program (AP4).

The NCI is assisting the formation of these partnerships by offering to academic and non-profit researchers a one-year planning grant, which is the subject of this RFA. The PIs will use the planning grant to study the feasibility of developing the pharmaceutical/non-profit/academic interaction necessary to establish and support a partnership, to hold a meeting of potential partners and select research projects for the potential AP4 Center. URL: http://grants1.nih.gov/grants/guide/rfa-files/RFA-CA-04-005.html

5. REMINDER AND UPDATE--STATUS OF NON-COMPETING GRANT PROGRESS REPORT NOTIFICATION (NOT-OD-03-054) 

This Notice updates the NIH extramural community on the status of non-competing grant progress report notification. Historically, NIH reminded grantees about the submission of a progress report by mailing a pre-printed face page. In August 2002 NIH announced a modification of this business process and discontinued this mailing (see http://grants.nih.gov/grants/guide/notice-files/NOT-OD-02-066.html). Since that time, the NIH Office of Extramural Research has hosted a website of Non-competing Progress Report due date information. URL: http://grants1.nih.gov/grants/guide/notice-files/NOT-OD-03-054.html

6. ESTABLISHED INVESTIGATOR AWARD IN CANCER PREVENTION, CONTROL, BEHAVIORAL, AND POPULATION SCIENCES (PAR-03-149) This Program Announcement (PAR) replaces PAR-00-039, which was published in the National Institutes of Health (NIH) Guide on January 10, 2000.  

The purpose of the NCI Established Investigator Award in Cancer Prevention, Control, Behavioral and Population Research (K05) is to provide established investigators protected time to devote to research and to act as mentors for new investigators and junior faculty members. URL: http://grants1.nih.gov/grants/guide/pa-files/PAR-03-149.html

7. CANCER EDUCATION AND CAREER DEVELOPMENT PROGRAM (PAR-03-148) This program announcement (PAR) replaces PAR-00-064, "Cancer Education and Career Development Program", which was published in the NIH guide on February 17, 2000.  

The purpose of NCI Cancer Education and Career Development Program (R25) is to train predoctoral and postdoctoral candidates in cancer research settings that are highly inter-disciplinary and collaborative. This Program requires sustained leadership, dedicated faculty time, specialized curriculum development and implementation, nterdisciplinary research environments, and more than one mentor per trainee to achieve career development research and education objectives. URL: http://grants1.nih.gov/grants/guide/pa-files/PAR-03-148.html

8. SPECIALIZED PROGRAMS OF RESEARCH EXCELLENCE (SPOREs) IN HUMAN CANCER FOR THE YEAR 2004 (NCI) (PAR-03-158) LETTER OF INTENT RECEIPT DATE:  Myeloma and Genitourinary Cancer SPOREs:      April 1, 2004 Breast and Gynecological Cancer SPOREs: August 1, 2004 APPLICATION RECEIPT DATE:  Myeloma and Genitourinary Cancer SPOREs:

June 1, 2004 Breast and Gynecological Cancer SPOREs: October 1, 2004 The Organ Systems Branch of the Office of the Deputy Director for Extramural Science at the National Cancer Institute (NCI) invites grant applications (P50) for Specialized Programs of Research Excellence (SPORE) in organ-specific cancers. URL: http://grants1.nih.gov/grants/guide/pa-files/PAR-03-158.html

 

9.  SMALL BUSINESS ELIGIBILITY REQUIREMENTS FOR APPLICANTS TO THE SMALL BUSINESS INNOVATION RESEARCH (SBIR) AND SMALL BUSINESS TECHNOLOGY TRANSFER (STTR) PROGRAMS (NOT-OD-03-053)

The purpose of this notice is to restate the eligibility requirements for a small business concern to participate in the NIH SBIR and STTR programs, and to express that NIH has not adopted any new policies concerning eligibility.

URL:  http://grants.nih.gov/grants/guide/notice-files/NOT-OD-03-053.html

10.  CELLULAR AND MOLECULAR IMAGING OF THE CARDIOVASCULAR, PULMONARY, AND HEMATOPOIETIC SYSTEMS (NHLBI, NIBIB, ICRH) (RFA-HL-04-003) LETTER OF INTENT RECEIPT DATE:  December 22, 2003 APPLICATION RECEIPT DATE:  January 22, 2004

The NHLBI, in collaboration with NIBIB and the Canadian Institute of Circulatory and Respiratory Health (ICRH), invites applications for the development and application of novel cellular and molecular imaging probes and technologies to image the cardiovascular, pulmonary, and hematopoietic systems in vivo. The first goal is to detect and quantify at the molecular and cellular level the cellular pathways that regulate heart, lung and blood function, and the abnormalities in these pathways occurring in heart, lung, blood and sleep disorders. The second goal is to develop new methods for cell tracking to monitor the movement and location of specific cell populations in vivo for application in cell-based therapeutics. This RFA will use the NIH R01 award mechanism.

URL:  http://grants.nih.gov/grants/guide/rfa-files/RFA-HL-04-003.html

OTHER ORGANIZATIONS

11.  SCAR IMAGING INFORMATICS GRANT PROGRAM

Application Deadline is September 5, 2003

The mission of The Society for Computer Applications in Radiology (SCAR) (http://www.scarnet.org) is to advance computer applications and information technology in medical imaging through education and research.  In support of this mission, the SCAR Research and Development Committee is pleased to offer two $40,000 grants for original research in medical informatics, restricted residents, fellows, or faculty in departments of diagnostic radiology, radiation oncology, or nuclear medicine as well as graduate students and postdoctoral fellows in imaging informatics or biomedical engineering.

URL:  http://www.scarnet.org/pdf/Grants_Applic03.pdf

_______________________

The Cancer Imaging Program at NCI has created this e-mail distribution list to notify interested people about funding opportunities and other issues related to imaging research.  Its primary purpose is to call your attention to important, relevant information on NIH Web pages, or in the NIH Guide.  Occasionally it may be used to clarify areas of confusion, or disseminate answers to frequently asked questions. If you wish to remain on the list, no action is necessary.  If you wish to be added to the list (or removed from it), please contact Ms. Johnnie Smith by return e-mail (js95x@nih.gov).

Cancer Imaging Program
Division of Cancer Treatment and Diagnosis, NCI
EPN, Room 6000 - MSC-7412
6130 Executive Boulevard
Bethesda, MD 20892-7412
Tel: 301 496 9531
Fax: 301 480 3507